---
figid: PMC10299185__IJNS-09-00031-g001
pmcid: PMC10299185
image_filename: PMC10299185__IJNS-09-00031-g001.jpg
figure_link: /pmc/articles/PMC10299185/figure/F1/
number: Figure 1
figure_title: Metabolic pathway involved in FD.
caption: Metabolic pathway involved in FD. Î±GalA deficiency, due to the GLA gene pathogenic
  variant, leads to lysosomal storage of globotriaosylcramide (Gb3) and related glycosphingolipids
  (for example, its deacylated form, globotriaosylsphingosine or lysoGb3)
article_title: 'Newborn Screening for Fabry Disease: Current Status of Knowledge'
citation: Vincenza Gragnaniello, et al. Int J Neonatal Screen. 2023 Jun;9(2).
year: '2023'
pub_date: 2023-6-
epub_date: 2023-6-05
doi: 10.3390/ijns9020031
journal_title: International Journal of Neonatal Screening
journa_nlm_ta: Int J Neonatal Screen
publisher_name: MDPI
keywords:
- Fabry disease
- newborn screening
- lysosomal storage disease
- digital microfluidics
- tandem mass spectrometry
- second tier test
- LysoGb3
---
